Antibody response of infants in tropics to five doses of oral polio vaccine Three doses of oral polio vaccine (OPV), as currently recommended, are not sufficient for effective immunisation of infants in tropical countries owing to poor seroconversion rates.1 2 Consequently paralytic poliomyelitis does occur in vaccinated populations.3 The seroconversion rates of infants to five doses of OPV are reported here.
Subjects, methods, and results
All infants were aged between 6 and 51 weeks when the first dose of OPV was given, by methods described elsewhere.4 During the course of investigations the titre of OPV was repeatedly checked and found unchanged from the recommended levels.4 The interval between doses was four weeks except in a few children in whom it was five or six weeks. Blood was collected from vaccinees immediately before giving the first dose of OPV, and again four weeks after the third dose, when a fourth dose was given. A third sample of blood was collected four weeks after the fifth dose. All sera were tested for the presence and titre of neutralising antibodies at a starting dilution of 1/8, against 100-300 TCID50 of poliovirus types 1, 2, and 3.4
A total of 78 infants were studied. Sera taken from 55 infants after the third dose of OPV were promptly tested along with their prevaccination sera. Thirty-three infants (60 %) who had already seroconverted to the three types of poliovirus, and had received a fourth dose, were not given a fifth dose as no further seroconversions were to be gained in them. The remaining 45 infants were given a fifth dose, and four weeks later 21 were found to have seroconverted to all three types. Sixteen had seroconverted to two types only, and six to one type; two infants remained seronegative to three types.
Since the assessment of seroresponse to five doses of OPV would be biased if only the 45 infants were included and the 33 excluded from analysis, all infants are considered together. Among the total of 78 infants studied, 76 (97 %) responded to one or more serotypes and 54 (69 %) responded to all three serotypes. The type-specific seroconversion rates are shown in the table.
Discussion
Seroresponses of infants and children to one and two doses of OPV, and of infants to three doses, have been described from this laboratory,2 4 using similar methods (see The intravenous and oral routes of prostaglandin administration for labour induction have side effects-notably vomiting, diarrhoea, and uterine hypertonus. In an attempt to obviate these we decided to induce labour by administering prostaglandin by the buccal route. This technique has not been previously reported.
Patients, methods, and results
Labour was induced for obstetric reasons in 24 women at term. Immediately after low amniotomy prostaglandin E2 tablets were placed in the buccal space between the cheek and the gum above the upper molars. The 0-5 mg tablets were administered according to two schemes. The first 12 subjects received a fixed dose of 0-5 mg every 30 minutes and the remaining 12 an incremental dose that was titrated according to the uterine responsethat is, 0-5 mg, 0-5 mg, 1-00 mg, 1-00 mg, 2-00 mg, 2-00 mg every 30 minutes. A maximum dose of 2-00 mg (four tablets) half-hourly was given. Induction was considered successful if 5-cm dilatation of the cervix or delivery was achieved within 12 hours.
In the fixed-dose group 11 patients were successfully induced, as were 10 of the 12 on incremental doses. The 
Case reports
Case 1-A 50-year-old Black woman was first seen in 1956 with a six-month history of pleuritic chest pain and arthritis of the fingers, wrists, and elbows. Homozygous sickle-cell disease was diagnosed from alkaline haemoglobin electrophoresis, a positive sickling test, and a characteristic blood film.
Levels of Hb A2 were not measured but were not visibly raised on paper electrophoresis. Haemoglobin was 6-5 g/dl, mean corpuscular haemoglobin concentration 27 g/dl, reticulocytes 13 %, and fetal haemoglobin 13 %. During the next 10 years she continued to have exacerbations of the arthritis. In 1967 she was readmitted in congestive cardiac failure. Her blood pressure was 150190 mm Hg, she had spindling of the proximal interphalangeal joints, active synovitis of the wrists, and finger clubbing. Her temperature varied between 37-2°C and 37 9°C. Haemoglobin was 8-8 g/dl, reticulocytes 3-5 %, and white cell count 5-6 x109/1. The antistreptolysin 0 titre was normal, serum total protein 68 g/l and albumin 32 g/l, blood urea 7-8 mmol/l (47 mg/100 ml) rising to 17 mmol/l (103 mg/l00 ml), ESR 143 mm in 1 h, venereal disease research laboratory test negative. Nine blood cultures were sterile. LE pteparations were strongly positive on five occasions. There were many pus cells, occasional red blood cells, and granular and hyaline casts in the urine. Chest x-ray examination showed cardiac enlargement with diffuse pulmonary infiltration in the lower zones compatible with fibrosis or infiltration. Her fever and arthralgia failed to respond to salicylates. Prednisone 40 mg daily was started, and was increased to 80 mg daily when she became psychotic and had continued fever. It had little effect, and she died suddenly after 10 days. Necropsy showed no evidence of valvular disease or of infectious or Libman-Sachs endocarditis.
Case 2-The patient was a 16-year-old Black girl who had been admitted to hospital 13 times previously, nine of them for pneumonia. When she was 4 months old homozygous sickle-cell disease was diagnosed on haemoglobin electrophoresis at alkaline and acid pH, positive sickle test, and the presence of the sickle-cell trait in both parents. On admission she had a two-week history of jaundice, pleuritic chest pain, and swelling of both knees and ankles. She was jaundiced, had clubbing of fingers and toes, and 18-cm hepatic enlargement. The spleen was impalpable. Both knees were warm and contained small effusions. Investigations showed heamoglobin 6 1 g/dl; white cell count 9-1 X 109/1, 68% neutrophils; prothrombin time normal; electrolytes normal; plasma creatinine 53 pmol/l (0 6 mg/100 ml), total bilirubin 410 ,umol/l (24 mg/ 100 ml) (50 % conjugated), alkaline phosphatase 53 KAU. Blood and urine cultures were persistently sterile and the serum was Australia antigen negative. Creatinine clearance was 0-9 mmol (100 mg)/ min, and urine protein 700 mg/24 h. Antinuclear factor (ANF) tests were consistently positive and DNA binding values (Farr assay) were 50% and 60 % (normal 0-30 %), C3 was 0-72 g/l (normal 1P2-16 g/l). Three days after admission she developed a persistent fever. Treatment with prednisone 60 mg daily was started after 22 days and the temperature fell to normal immediately. She improved clinically and her liver function tests reverted to normal. Six months later she was taking prednisone 10 mg daily, had returned to school, and was clinically well.
Discussion
In each case homozygous sickle-cell disease was diagnosed on adequate evidence. In case 1 five of the American Rheumatism Association criteria for the diagnosis of SLE were met by the presence of pleurisy, arthritis, LE cells, psychosis, and casts in the urine. In case 2 SLE was diagnosed on the arthritis, proteinuria, strongly positive ANF, high DNA binding, and hypocomplementaemia. Although joint symptoms are common in sickle-cell disease these usually arise in the juxta-articular bone and are referred to the joint. The finger clubbing and hepatomegaly in both cases remain unexplained, although an association of gross hepatomegaly and clubbing in sickle-cell disease has been reported.2
The occurrence of SLE in sickle-cell anaemia is of theoretical interest because of the immunological aspects of the two diseases. Johnston et al3 have reported a selective abnormality of the alternative pathway of complement activation in patients with sickle-cell disease in whom the C3 and total haemolytic complement (CHM ) levels were normal. In studies still in progress we have confirmed this and shown that it is related to a partial deficiency in factor B (glycine-rich B protein), which is a component not only of the alternative pathway but also of the C3b feedback amplification system.4 Such a defect might be partly responsible for the increased susceptibility of sicklecell patients to infection. Immune complex diseases-particularly SLE-may be associated with genetic deficiencies of various components of complement, and complement deficiency may lead to such diseases through failure to eliminate foreign viral, bacterial, or other antigens. The defect in complement metabolism in sickle-cell anaemia may similarly lead not onlv to recurrent infection but possibly to immune complex disease.
